Identification of Potential Biomarkers and Drugs for PapillaryThyroid Carcinoma Using Computational Analysis and MolecularDocking
The hub gene CCND1 and its targeting drug candidate Tipifarnib may contribute to PTC treatment.
Authors
- Sihai Wang
- Jiejun Tan
- Zhaohui Fang
- Fuli Zhang (ORCID: https://orcid.org/0000-0002-4175-4795)
- Zheng Bi
- Liwang Ma (ORCID: https://orcid.org/0000-0002-7451-5221)
- Tiantian Wang (ORCID: https://orcid.org/0000-0001-8223-3956)
Institutions
- Bengbu Medical College (CN)
- Anhui Medical University (CN)
- Anhui University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Heilongjiang University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-10-28
- DOI
- https://doi.org/10.2174/0109298673422926251009064453
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00